190 related articles for article (PubMed ID: 33452405)
21.
Gethings-Behncke C; Coleman HG; Jordao HWT; Longley DB; Crawford N; Murray LJ; Kunzmann AT
Cancer Epidemiol Biomarkers Prev; 2020 Mar; 29(3):539-548. PubMed ID: 31915144
[TBL] [Abstract][Full Text] [Related]
22. Association of Antibody Responses to Fusobacterium nucleatum and Streptococcus gallolyticus Proteins with Colorectal Adenoma and Colorectal Cancer.
Genua F; Butt J; Waterboer T; Hughes DJ
Dig Dis Sci; 2023 Aug; 68(8):3300-3311. PubMed ID: 37338617
[TBL] [Abstract][Full Text] [Related]
23. Expression of EBV antibody EA-IgA, Rta-IgG and VCA-IgA and SA in serum and the implication of combined assay in nasopharyngeal carcinoma diagnosis.
Xia C; Zhu K; Zheng G
Int J Clin Exp Pathol; 2015; 8(12):16104-10. PubMed ID: 26884888
[TBL] [Abstract][Full Text] [Related]
24. Association of Dietary Patterns With Risk of Colorectal Cancer Subtypes Classified by Fusobacterium nucleatum in Tumor Tissue.
Mehta RS; Nishihara R; Cao Y; Song M; Mima K; Qian ZR; Nowak JA; Kosumi K; Hamada T; Masugi Y; Bullman S; Drew DA; Kostic AD; Fung TT; Garrett WS; Huttenhower C; Wu K; Meyerhardt JA; Zhang X; Willett WC; Giovannucci EL; Fuchs CS; Chan AT; Ogino S
JAMA Oncol; 2017 Jul; 3(7):921-927. PubMed ID: 28125762
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of antibody level against Fusobacterium nucleatum in the serological diagnosis of colorectal cancer.
Wang HF; Li LF; Guo SH; Zeng QY; Ning F; Liu WL; Zhang G
Sci Rep; 2016 Sep; 6():33440. PubMed ID: 27678333
[TBL] [Abstract][Full Text] [Related]
26. Fusobacterium nucleatum envelope protein FomA is immunogenic and binds to the salivary statherin-derived peptide.
Nakagaki H; Sekine S; Terao Y; Toe M; Tanaka M; Ito HO; Kawabata S; Shizukuishi S; Fujihashi K; Kataoka K
Infect Immun; 2010 Mar; 78(3):1185-92. PubMed ID: 20008529
[TBL] [Abstract][Full Text] [Related]
27. Induction of systemic murine B-cell responses by Fusobacterium nucleatum and Porphyromonas gingivalis.
Nunes IP; Jonsson R; Jensen HB; Bakken V
Oral Microbiol Immunol; 1996 Jun; 11(3):142-9. PubMed ID: 8941767
[TBL] [Abstract][Full Text] [Related]
28. Association of Fusobacterium nucleatum with clinical and molecular features in colorectal serrated pathway.
Ito M; Kanno S; Nosho K; Sukawa Y; Mitsuhashi K; Kurihara H; Igarashi H; Takahashi T; Tachibana M; Takahashi H; Yoshii S; Takenouchi T; Hasegawa T; Okita K; Hirata K; Maruyama R; Suzuki H; Imai K; Yamamoto H; Shinomura Y
Int J Cancer; 2015 Sep; 137(6):1258-68. PubMed ID: 25703934
[TBL] [Abstract][Full Text] [Related]
29. The ELISA system for measuring antibody reactive to Fusobacterium nucleatum in the sera of patients with chronic periodontitis.
Falkler WA; Lai R; Vincent JW; Dober L; Spiegel C; Hayduk S
J Periodontol; 1982 Dec; 53(12):762-6. PubMed ID: 6818334
[TBL] [Abstract][Full Text] [Related]
30. Fusobacterium nucleatum in colorectal carcinoma tissue and patient prognosis.
Mima K; Nishihara R; Qian ZR; Cao Y; Sukawa Y; Nowak JA; Yang J; Dou R; Masugi Y; Song M; Kostic AD; Giannakis M; Bullman S; Milner DA; Baba H; Giovannucci EL; Garraway LA; Freeman GJ; Dranoff G; Garrett WS; Huttenhower C; Meyerson M; Meyerhardt JA; Chan AT; Fuchs CS; Ogino S
Gut; 2016 Dec; 65(12):1973-1980. PubMed ID: 26311717
[TBL] [Abstract][Full Text] [Related]
31. Alteration of microRNA-4474/4717 expression and CREB-binding protein in human colorectal cancer tissues infected with Fusobacterium nucleatum.
Feng YY; Zeng DZ; Tong YN; Lu XX; Dun GD; Tang B; Zhang ZJ; Ye XL; Li Q; Xie JP; Mao XH
PLoS One; 2019; 14(4):e0215088. PubMed ID: 30951563
[TBL] [Abstract][Full Text] [Related]
32. FadA promotes DNA damage and progression of Fusobacterium nucleatum-induced colorectal cancer through up-regulation of chk2.
Guo P; Tian Z; Kong X; Yang L; Shan X; Dong B; Ding X; Jing X; Jiang C; Jiang N; Yu Y
J Exp Clin Cancer Res; 2020 Sep; 39(1):202. PubMed ID: 32993749
[TBL] [Abstract][Full Text] [Related]
33. Berberine may rescue Fusobacterium nucleatum-induced colorectal tumorigenesis by modulating the tumor microenvironment.
Yu YN; Yu TC; Zhao HJ; Sun TT; Chen HM; Chen HY; An HF; Weng YR; Yu J; Li M; Qin WX; Ma X; Shen N; Hong J; Fang JY
Oncotarget; 2015 Oct; 6(31):32013-26. PubMed ID: 26397137
[TBL] [Abstract][Full Text] [Related]
34. TOX expression decreases with progression of colorectal cancers and is associated with CD4 T-cell density and Fusobacterium nucleatum infection.
Chen T; Li Q; Zhang X; Long R; Wu Y; Wu J; Fu X
Hum Pathol; 2018 Sep; 79():93-101. PubMed ID: 29792893
[TBL] [Abstract][Full Text] [Related]
35. Fecal Fusobacterium nucleatum for the diagnosis of colorectal tumor: A systematic review and meta-analysis.
Zhang X; Zhu X; Cao Y; Fang JY; Hong J; Chen H
Cancer Med; 2019 Feb; 8(2):480-491. PubMed ID: 30636375
[TBL] [Abstract][Full Text] [Related]
36. Replication Study:
Repass J;
Elife; 2018 Mar; 7():. PubMed ID: 29533182
[TBL] [Abstract][Full Text] [Related]
37. First steps towards combining faecal immunochemical testing with the gut microbiome in colorectal cancer screening.
Grobbee EJ; Lam SY; Fuhler GM; Blakaj B; Konstantinov SR; Bruno MJ; Peppelenbosch MP; Kuipers EJ; Spaander MC
United European Gastroenterol J; 2020 Apr; 8(3):293-302. PubMed ID: 32213018
[TBL] [Abstract][Full Text] [Related]
38.
Chen Y; Chen Y; Zhang J; Cao P; Su W; Deng Y; Zhan N; Fu X; Huang Y; Dong W
Theranostics; 2020; 10(1):323-339. PubMed ID: 31903123
[No Abstract] [Full Text] [Related]
39. Effects of metronidazole on colorectal cancer occurrence and colorectal cancer liver metastases by regulating Fusobacterium nucleatum in mice.
Wang M; Li Y; Yang X; Liu Z; Wang K; Gong D; Li J
Immun Inflamm Dis; 2023 Nov; 11(11):e1067. PubMed ID: 38018574
[TBL] [Abstract][Full Text] [Related]
40. Diets That Promote Colon Inflammation Associate With Risk of Colorectal Carcinomas That Contain Fusobacterium nucleatum.
Liu L; Tabung FK; Zhang X; Nowak JA; Qian ZR; Hamada T; Nevo D; Bullman S; Mima K; Kosumi K; da Silva A; Song M; Cao Y; Twombly TS; Shi Y; Liu H; Gu M; Koh H; Li W; Du C; Chen Y; Li C; Li W; Mehta RS; Wu K; Wang M; Kostic AD; Giannakis M; Garrett WS; Hutthenhower C; Chan AT; Fuchs CS; Nishihara R; Ogino S; Giovannucci EL
Clin Gastroenterol Hepatol; 2018 Oct; 16(10):1622-1631.e3. PubMed ID: 29702299
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
